A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma

Pera, 2005, Epidemiology of esophageal adenocarcinoma, J Surg Oncol, 92, 151, 10.1002/jso.20357 Brown, 2008, Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage and age, J Natl Cancer Inst, 100, 1184, 10.1093/jnci/djn211 Lagergren, 1999, Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma, N Engl J Med, 340, 825, 10.1056/NEJM199903183401101 Wong, 2005, Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma, Clin Gastroenterol Hepatol, 3, 1, 10.1016/S1542-3565(04)00602-0 Bird-Lieberman, 2008, Barrett's esophagus, Gastroenterol Clin N Am, 37, 921, 10.1016/j.gtc.2008.09.003 Wild, 2003, Reflux, Barrett's oesophagus and adenocarcinoma: burning questions, Nat Rev Cancer, 3, 676, 10.1038/nrc1166 McManus, 2004, Biomarkers of esophageal adenocarcinoma and Barrett's esophagus, Cancer Res, 64, 1561, 10.1158/0008-5472.CAN-03-2438 Fitzgerald, 2006, Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma, Gut, 55, 1810, 10.1136/gut.2005.089144 Shaheen, 2002, Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review, JAMA, 287, 1972, 10.1001/jama.287.15.1972 Casson, 2003, Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma, Cancer Detect Prev, 27, 139, 10.1016/S0361-090X(03)00033-3 Whiteman, 2008, Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus, Gut, 57, 173, 10.1136/gut.2007.131375 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 Veugelers, 2006, Obesity and lifestyle risk factors for gastroesophageal reflux disease. Barrett esophagus and esophageal adenocarcinoma, Dis Esophagus, 19, 321, 10.1111/j.1442-2050.2006.00602.x Chow, 1998, Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia, J Natl Cancer Inst, 90, 150, 10.1093/jnci/90.2.150 Lagergren, 1999, Association between body mass and adenocarcinoma of the esophagus and gastric cardia, Ann Intern Med, 130, 883, 10.7326/0003-4819-130-11-199906010-00003 Wu, 2001, A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States), Cancer Causes Control, 12, 721, 10.1023/A:1011290704728 Mayne, 2002, Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans, J Nutr, 132, 3467, 10.1093/jn/132.11.3467S Corley, 2008, Abdominal obesity and the risk of esophageal and gastric cardia carcinomas, Cancer Epidemiol Biomarkers Prev, 17, 352, 10.1158/1055-9965.EPI-07-0748 Hampel, 2005, Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications, Ann Intern Med, 143, 199, 10.7326/0003-4819-143-3-200508020-00006 Kubo, 2006, Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis, Cancer Epidemiol Biomarkers Prev, 15, 872, 10.1158/1055-9965.EPI-05-0860 Gupta, 2002, Insulin: a novel factor in carcinogenesis, Am J Med Sci, 323, 140, 10.1097/00000441-200203000-00004 Yu, 2000, Role of the insulin-like growth factor family in cancer development and progression, J Natl Cancer Inst, 92, 1472, 10.1093/jnci/92.18.1472 Furstenberger, 2002, Insulin-like growth factors and cancer, Lancet Oncol, 3, 298, 10.1016/S1470-2045(02)00731-3 Grimberg, 2003, Mechanisms by which IGF-I may promote cancer, Cancer Biol Ther, 2, 630, 10.4161/cbt.2.6.678 Larsson, 2005, Role of insulin-like growth factor 1 receptor signalling in cancer, Br J Cancer, 92, 2097, 10.1038/sj.bjc.6602627 Samani, 2007, The role of the IGF system in cancer growth and metastasis: overview and recent insights, Endocr Rev, 28, 20, 10.1210/er.2006-0001 Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354 Wolf, 2005, Diabetes mellitus and breast cancer, Lancet Oncol, 6, 103, 10.1016/S1470-2045(05)01736-5 El-Serag, 2006, The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence, Clin Gastroenterol Hepatol, 4, 369, 10.1016/j.cgh.2005.12.007 Rochester, 2007, The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer, BJU Int, 100, 1396, 10.1111/j.1464-410X.2007.06931.x Hudelist, 2007, Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations, Endocr Relat Cancer, 14, 1053, 10.1677/ERC-06-0075 Weber, 2002, Overexpression of the insulin-like growth factor I receptor in human colon carcinomas, Cancer, 95, 2086, 10.1002/cncr.10945 Barnard, 1995, Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology, Gastroenterology, 108, 564, 10.1016/0016-5085(95)90087-X Qureshi, 1997, EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells, J Surg Res, 69, 354, 10.1006/jsre.1997.5080 Bonafe, 2003, Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control, J Clin Endocrinol Metab, 88, 3299, 10.1210/jc.2002-021810 Casson, 2005, Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma, Cancer, 104, 730, 10.1002/cncr.21229 Casson, 2005, Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma, Carcinogenesis, 26, 1536, 10.1093/carcin/bgi115 Balogh, 2006, Lack of association between insulin-like growth factor I receptor G(+3174)A polymorphism and retinopathy of prematurity, Graefes Arch Clin Exp Ophthalmol, 244, 1035, 10.1007/s00417-005-0203-4 Rasmussen, 2000, Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus, J Clin Endocrinol Metab, 85, 1606, 10.1210/jc.85.4.1606 Doecke, 2008, Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers, Cancer Epidemiol Biomarkers Prev, 17, 1007, 10.1158/1055-9965.EPI-08-0023 Gram, 2006, Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women, Int J Obes (Lond), 30, 1623, 10.1038/sj.ijo.0803324 Gunter, 2008, A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer, Cancer Epidemiol Biomarkers Prev, 17, 921, 10.1158/1055-9965.EPI-07-2686 Moore, 2008, Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels, Cancer Res, 68, 3680, 10.1158/0008-5472.CAN-07-6271 Siahpush, 2007, Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus, Cancer Epidemiol Biomarkers Prev, 16, 2387, 10.1158/1055-9965.EPI-06-0986 Chu, 2008, Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I, Cancer Epidemiol Biomarkers Prev, 17, 3268, 10.1158/1055-9965.EPI-08-0073 Garte, 2001, Metabolic gene polymorphism frequencies in control populations, Cancer Epidemiol Biomarkers Prev, 10, 1239